4588.T
Oncolys BioPharma Inc.
グロース · 医薬品 · 医薬品 · JP
JPY 4,070.00
−0.49%Margins
Gross margin
102.0%
EBITDA margin
-7227.7%
EBIT margin
-7228.6%
Net margin
-7350.0%
FCF margin
-6939.3%
-51.5%
Return on equity
-45.2%
Return on assets
-47.1%
Return on invested capital
0.01x
Asset turnover
-JPY 1.9B
Cash from operations
JPY 351
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026